Back to top

Insider Cashes In: Major Protagonist Therapeutics Stock Sale Shakes Up Investors

New insider activity at Protagonist Therapeutics ( ($PTGX) ) has taken place on June 25, 2026. Director William Waddill of Protagonist Therapeutics...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Invesco Financial Preferred ETF (PGF)

Protagonist Therapeutics, Inc. (PTGX)